Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors-Reference-Cited by-同舟云学术

Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors

Published:2019-06 Issue: Volume:164 Page:252-262
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Alqarni Iman,Bassiouni Yieldez A.,Badr Amira M.^ORCID,Ali Rehab A.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference59 articles.

1. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease;Mota;Metabolism-Clin. Exp.,2016

2. Adipokines and non-alcoholic fatty liver disease: multiple interactions;Adolph;Int. J. Mol. Sci.,2017

3. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: what we need in the future;Araujo;Liver Int,2018

4. In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD);Kanuri;Int. J. Mol. Sci.,2013

5. Role of toll-like receptors and their downstream molecules in the development of nonalcoholic fatty liver disease;Miura;Gastroenterol. Res. Practice,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review;Metabolites;2024-06-20

2. Exploring the potential of drug repurposing for liver diseases: A comprehensive study;Life Sciences;2024-06

3. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy;Cell Communication and Signaling;2024-05-02

4. The effect of different treatment strategies on glycolipid metabolism disorders and cardiovascular events in primary aldosteronism;Hypertension Research;2024-04-02

5. Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials;Nutrients;2024-03-23